Skip to content
healthcare.dev

ELFABRIO

NDC 10122-165, pegunigalsidase alfa, injection, solution, concentrate, from Chiesi USA, Inc..

Product NDC
10122-165
Status
Listed
Labeler
Chiesi USA, Inc.
Dosage form
INJECTION, SOLUTION, CONCENTRATE
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761161
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10122-165 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PEGUNIGALSIDASE ALFA5 mg/2.5mL
Package NDCNDC-11Package
10122-165-02101220165021 VIAL, SINGLE-DOSE in 1 CARTON (10122-165-02) / 2.5 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6fb674bf-744e-431f-92ef-b2a5a66c8cf3
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=10122-165

Use it

Look up 10122-165 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10122-165 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10122-165. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.